<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To explore the associations of <z:chebi fb="15" ids="39026">LDL</z:chebi> (<z:chebi fb="2" ids="39026">low-density lipoprotein</z:chebi>) particle size and oxidized <z:chebi fb="15" ids="39026">LDL</z:chebi> with endothelium-dependent function of the forearm microcirculation in <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Endothelium-dependent function was examined in 43 middle-aged men and women with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and 10 age-matched controls </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> received aspirin to inhibit endothelial cyclo-oxygenase </plain></SENT>
<SENT sid="3" pm="."><plain>Forearm blood flow (FBF) was measured using venous occlusion plethysmography with separate administration of <z:chebi fb="9" ids="15355">acetylcholine</z:chebi> (<z:chebi fb="0" ids="15355">ACh</z:chebi>) and bradykinin (BK) into the brachial artery </plain></SENT>
<SENT sid="4" pm="."><plain>Endothelium-independent function was assessed using <z:chebi fb="0" ids="29321">sodium nitroprusside</z:chebi> (SNP) </plain></SENT>
<SENT sid="5" pm="."><plain>N(G)-monomethyl-<z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> (<z:chebi fb="0" ids="28229">L-NMMA</z:chebi>) was co-infused with <z:chebi fb="0" ids="15355">ACh</z:chebi> (<z:chebi fb="0" ids="15355">ACh</z:chebi> + <z:chebi fb="0" ids="28229">L-NMMA</z:chebi>) and BK (BK + <z:chebi fb="0" ids="28229">L-NMMA</z:chebi>) to assess non-NO-mediated contributions to endothelium-dependent function </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Subjects with <z:mp ids='MP_0002055'>diabetes</z:mp> had impaired endothelium-dependent and endothelium-independent function compared with controls (p &lt; 0.01 for <z:chebi fb="0" ids="15355">ACh</z:chebi>, BK and SNP) </plain></SENT>
<SENT sid="7" pm="."><plain>In multivariate regression analysis, <z:chebi fb="15" ids="39026">LDL</z:chebi> size (r = 0.41 and p = 0.007), oxidized <z:chebi fb="15" ids="39026">LDL</z:chebi> (r = -0.41 and p = 0.007) and duration of <z:mp ids='MP_0002055'>diabetes</z:mp> (r = -0.37 and p = 0.02) predicted FBF response to <z:chebi fb="0" ids="15355">ACh</z:chebi> independently of age, gender and systolic blood pressure </plain></SENT>
<SENT sid="8" pm="."><plain>There were no associations between <z:chebi fb="15" ids="39026">LDL</z:chebi> size, oxidized <z:chebi fb="15" ids="39026">LDL</z:chebi>, duration of <z:mp ids='MP_0002055'>diabetes</z:mp> and FBF response to BK, SNP, <z:chebi fb="0" ids="15355">ACh</z:chebi> + <z:chebi fb="0" ids="28229">L-NMMA</z:chebi> or BK + <z:chebi fb="0" ids="28229">L-NMMA</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: In type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, small dense <z:chebi fb="15" ids="39026">LDL</z:chebi> particles, duration of <z:mp ids='MP_0002055'>diabetes</z:mp> and oxidized <z:chebi fb="15" ids="39026">LDL</z:chebi> may independently contribute to <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> of the microcirculation </plain></SENT>
<SENT sid="10" pm="."><plain>These disturbances may occur via a selective defect, because <z:chebi fb="0" ids="15355">ACh</z:chebi> and BK activate endothelial NO synthase via different G-protein signal transduction pathways </plain></SENT>
</text></document>